Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 781 is a predicted DNA-binding transcription factor, part of the zinc finger protein family. These proteins contain one or more conserved zinc finger motifs, most commonly the C2H2-type, which enable them to interact directly with DNA and regulate transcription. ZNF781 is localized in the nucleus and is part of the larger "zinc fingers" family, which includes many diverse proteins involved in gene regulation, development, cell differentiation, and other nuclear processes. Although hundreds of zinc finger proteins play vital roles in various biological functions and are implicated in disease processes such as cancer (e.g., ZNF281, ZNF750, ZNF185), direct disease associations or therapeutic relevance for ZNF781 have not yet been documented. Current evidence does not support ZNF781 as a receptor, enzyme, or transporter; it is classified as a predicted DNA-binding transcription factor, with molecular functions most closely tied to gene regulation within the nucleus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 781 (ZNF781).